ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Elicio Therapeutics
5.57
+0.6100
12.30%
盤後:
5.57
0.0000
0.00%
16:00 EDT
成交量:
5.97萬
成交額:
33.17萬
市值:
8,878.06萬
市盈率:
-1.31
高:
5.94
開:
5.04
低:
4.89
收:
4.96
資料載入中...
總覽
公司
新聞
公告
Elicio Therapeutics, Inc.盤中異動 大幅拉昇5.33%
市场透视
·
02-15
Elicio Therapeutics, Inc.盤中異動 早盤股價大漲6.58%
市场透视
·
02-10
Elicio Therapeutics, Inc.盤中異動 急速下挫7.09%報8.65美元
市场透视
·
02-03
Elicio Therapeutics, Inc.盤中異動 早盤快速下跌5.63%報8.89美元
市场透视
·
01-31
Elicio Therapeutics, Inc.盤中異動 股價大跌15.98%報8.10美元
市场透视
·
01-30
Elicio Therapeutics, Inc.盤中異動 急速上漲6.33%報8.23美元
市场透视
·
01-27
Elicio Therapeutics, Inc.盤中異動 快速拉昇5.49%
市场透视
·
01-24
Elicio Therapeutics, Inc.盤中異動 急速上漲6.51%報6.87美元
市场透视
·
01-23
Elicio Therapeutics, Inc.盤中異動 急速拉昇5.12%
市场透视
·
01-15
Elicio Therapeutics, Inc.盤中異動 股價大漲5.11%報5.96美元
市场透视
·
01-10
Elicio Therapeutics, Inc.盤中異動 早盤股價大漲6.14%報6.40美元
市场透视
·
01-08
Elicio Therapeutics, Inc.盤中異動 下午盤大幅上漲5.00%
市场透视
·
01-08
Elicio Therapeutics, Inc.盤中異動 早盤快速下跌5.20%
市场透视
·
01-06
Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.64%報5.43美元
市场透视
·
01-03
Elicio Therapeutics, Inc.盤中異動 急速跳水5.81%
市场透视
·
2024-12-21
Elicio Therapeutics, Inc.股價上漲11.00% 市值跌156.67萬美元
市场透视
·
2024-12-17
Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.08%報5.59美元
市场透视
·
2024-12-12
Elicio Therapeutics, Inc.盤中異動 股價大跌5.01%
市场透视
·
2024-12-11
Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.75%
市场透视
·
2024-12-09
Elicio Therapeutics, Inc.盤中異動 下午盤大幅跳水5.14%報4.80美元
市场透视
·
2024-12-06
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ELTX/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":5.57,"timestamp":1746734400000,"preClose":4.96,"halted":0,"volume":59661,"hourTrading":{"tag":"盘后","latestPrice":5.57,"preClose":5.57,"latestTime":"16:00 EDT","volume":228,"amount":1269.96,"timestamp":1746734401314},"delay":0,"floatShares":10249455,"shares":15939069,"eps":-4.25289,"marketStatus":"已收盤","change":0.61,"latestTime":"05-08 16:00:00 EDT","open":5.04,"high":5.94,"low":4.89,"amount":331715.1497,"amplitude":0.211694,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.25289,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":4.96,"postHourTrading":{"tag":"盘后","latestPrice":5.57,"preClose":5.57,"latestTime":"16:00 EDT","volume":228,"amount":1269.96,"timestamp":1746734401314},"volumeRatio":1.821287,"impliedVol":0.5777,"impliedVolPercentile":0.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","floatShares":10249455,"roa":"-101.64%","roe":"-170157.38%","lyrEps":-4.25289,"volumeRatio":1.821287,"shares":15939069,"dividePrice":0,"high":5.94,"amplitude":0.211694,"preClose":4.96,"low":4.89,"week52Low":3.3419,"pbRate":"-7.85","week52High":11.45,"institutionHeld":0,"latestPrice":5.57,"eps":-4.25289,"divideRate":0,"volume":59661,"delay":0,"ttmEps":-4.25289,"open":5.04,"prevYearClose":5.1,"prevWeekClose":5.5,"prevMonthClose":4.92,"prevQuarterClose":6.16,"fiveDayClose":5.02,"twentyDayClose":5.29,"sixtyDayClose":7.98},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELTX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511461563","title":"Elicio Therapeutics, Inc.盤中異動 大幅拉昇5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511461563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511461563?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 02:14","pubTimestamp":1739556867,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时14分,Elicio Therapeutics, Inc.股票出现波动,股价大幅上涨5.33%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021502142896234e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021502142896234e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ELTX"],"gpt_icon":0},{"id":"2510286325","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510286325?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 22:31","pubTimestamp":1739197902,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分,Elicio Therapeutics, Inc.股票出现波动,股价快速拉升6.58%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223142a240a1e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223142a240a1e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2508869142","title":"Elicio Therapeutics, Inc.盤中異動 急速下挫7.09%報8.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508869142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508869142?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 23:12","pubTimestamp":1738595549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时12分,Elicio Therapeutics, Inc.股票出现波动,股价急速跳水7.09%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231229987975c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231229987975c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2507034965","title":"Elicio Therapeutics, Inc.盤中異動 早盤快速下跌5.63%報8.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507034965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507034965?lang=zh_tw&edition=fundamental","pubTime":"2025-01-31 22:38","pubTimestamp":1738334306,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时38分,Elicio Therapeutics, Inc.股票出现波动,股价大幅下跌5.63%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223826a23543af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223826a23543af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ELTX","LENZ"],"gpt_icon":0},{"id":"2507353621","title":"Elicio Therapeutics, Inc.盤中異動 股價大跌15.98%報8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507353621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507353621?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 22:32","pubTimestamp":1738247527,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分,Elicio Therapeutics, Inc.股票出现异动,股价急速跳水15.98%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223207a2345521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223207a2345521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ELTX"],"gpt_icon":0},{"id":"2506306278","title":"Elicio Therapeutics, Inc.盤中異動 急速上漲6.33%報8.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506306278?lang=zh_tw&edition=fundamental","pubTime":"2025-01-27 22:54","pubTimestamp":1737989696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时54分,Elicio Therapeutics, Inc.股票出现异动,股价急速上涨6.33%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225457abba64dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225457abba64dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2505862503","title":"Elicio Therapeutics, Inc.盤中異動 快速拉昇5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505862503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505862503?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 23:38","pubTimestamp":1737733106,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时38分,Elicio Therapeutics, Inc.股票出现异动,股价急速上涨5.49%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233826abb75ea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233826abb75ea7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ELTX","BK4139"],"gpt_icon":0},{"id":"2505777648","title":"Elicio Therapeutics, Inc.盤中異動 急速上漲6.51%報6.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505777648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505777648?lang=zh_tw&edition=fundamental","pubTime":"2025-01-23 03:19","pubTimestamp":1737573584,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时19分,Elicio Therapeutics, Inc.股票出现波动,股价快速上涨6.51%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123031944abb4dfd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123031944abb4dfd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2503134507","title":"Elicio Therapeutics, Inc.盤中異動 急速拉昇5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503134507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503134507?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 01:54","pubTimestamp":1736877260,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时54分,Elicio Therapeutics, Inc.股票出现异动,股价大幅拉升5.12%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.64%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150154209603a150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150154209603a150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2502867638","title":"Elicio Therapeutics, Inc.盤中異動 股價大漲5.11%報5.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502867638?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 22:48","pubTimestamp":1736520485,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时48分,Elicio Therapeutics, Inc.股票出现异动,股价急速上涨5.11%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.92%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102248059861ec9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102248059861ec9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2502777551","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲6.14%報6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502777551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502777551?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 23:33","pubTimestamp":1736350433,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时33分,Elicio Therapeutics, Inc.股票出现波动,股价快速拉升6.14%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233353985f84e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233353985f84e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ELTX"],"gpt_icon":0},{"id":"2501736877","title":"Elicio Therapeutics, Inc.盤中異動 下午盤大幅上漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501736877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501736877?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 02:29","pubTimestamp":1736274594,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日02时29分,Elicio Therapeutics, Inc.股票出现波动,股价快速拉升5.00%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108022954aba2117e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108022954aba2117e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2501258002","title":"Elicio Therapeutics, Inc.盤中異動 早盤快速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501258002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501258002?lang=zh_tw&edition=fundamental","pubTime":"2025-01-06 22:55","pubTimestamp":1736175302,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时55分,Elicio Therapeutics, Inc.股票出现波动,股价急速跳水5.20%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106225502a2179bc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106225502a2179bc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ELTX","BK4139"],"gpt_icon":0},{"id":"2500111413","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.64%報5.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500111413?lang=zh_tw&edition=fundamental","pubTime":"2025-01-03 22:31","pubTimestamp":1735914672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分,Elicio Therapeutics, Inc.股票出现波动,股价大幅拉升5.64%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223112a21468a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223112a21468a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ELTX","BK4139"],"gpt_icon":0},{"id":"2493424202","title":"Elicio Therapeutics, Inc.盤中異動 急速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493424202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493424202?lang=zh_tw&edition=fundamental","pubTime":"2024-12-21 01:49","pubTimestamp":1734716956,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时49分,Elicio Therapeutics, Inc.股票出现异动,股价大幅跳水5.81%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2492077961","title":"Elicio Therapeutics, Inc.股價上漲11.00% 市值跌156.67萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492077961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492077961?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 23:43","pubTimestamp":1734450194,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时43分,Elicio Therapeutics, Inc.股票出现异动,股价大幅上涨11.00%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723431495ea33b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723431495ea33b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2490826663","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.08%報5.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490826663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490826663?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 22:32","pubTimestamp":1734013934,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时32分,Elicio Therapeutics, Inc.股票出现异动,股价大幅上涨5.08%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223215a1e950d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223215a1e950d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2490414520","title":"Elicio Therapeutics, Inc.盤中異動 股價大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490414520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490414520?lang=zh_tw&edition=fundamental","pubTime":"2024-12-11 01:55","pubTimestamp":1733853346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时55分,Elicio Therapeutics, Inc.股票出现波动,股价快速下跌5.01%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.79%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211015547ab6d4eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211015547ab6d4eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ELTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2490779253","title":"Elicio Therapeutics, Inc.盤中異動 早盤股價大漲5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490779253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490779253?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 23:27","pubTimestamp":1733758030,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时27分,Elicio Therapeutics, Inc.股票出现异动,股价急速拉升5.75%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209232710a1e0c651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209232710a1e0c651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2489499832","title":"Elicio Therapeutics, Inc.盤中異動 下午盤大幅跳水5.14%報4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489499832?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 02:45","pubTimestamp":1733424302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日02时45分,Elicio Therapeutics, Inc.股票出现异动,股价急速下挫5.14%。Elicio Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Elicio Therapeutics, Inc.公司简介:Elicio Therapeutics Inc 是一家临床阶段的生物技术公司,致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206024502a1d70dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206024502a1d70dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","LENZ","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"ELTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.02},{"market":"US","date":"2024-11-13","symbol":"ELTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.81,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2024-08-13","symbol":"ELTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.96,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2024-05-15","symbol":"ELTX","fiscalQuarterEnding":"2024/03","expectedEps":-1.09,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-1.15},{"market":"US","date":"2024-03-29","symbol":"ELTX","fiscalQuarterEnding":"2023/12","expectedEps":-0.79,"name":null,"time":"盤前","type":"earning","dateTimestamp":1711684800000,"reportTimeType":"pre","actualEps":-3.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELTX","date":"2025-05-07","current":-1.575541,"percent":0.520737,"low":-9.235249,"twenty":-2.597448,"median":-1.624681,"eighty":-1.227443,"high":-0.963611,"avg":-1.952064,"sd":1.021351,"marketCap":81767423},"quantilePoints":[{"date":"2023-06-09","current":-9.235249,"twenty":-9.235249,"median":-9.19865,"eighty":-8.861936,"marketCap":260505032},{"date":"2023-06-16","current":-4.797096,"twenty":-9.19133,"median":-5.471097,"eighty":-5.286091,"marketCap":135315000},{"date":"2023-06-23","current":-3.669177,"twenty":-9.011993,"median":-5.35246,"eighty":-4.343178,"marketCap":103499000},{"date":"2023-06-30","current":-3.232452,"twenty":-8.711878,"median":-5.281964,"eighty":-3.931212,"marketCap":91180000},{"date":"2023-07-07","current":-3.782657,"twenty":-7.82363,"median":-4.797096,"eighty":-3.594899,"marketCap":106700000},{"date":"2023-07-14","current":-3.799851,"twenty":-5.457342,"median":-4.009616,"eighty":-3.669177,"marketCap":107185000},{"date":"2023-07-21","current":-3.868626,"twenty":-5.416077,"median":-3.868626,"eighty":-3.616907,"marketCap":109125000},{"date":"2023-07-28","current":-3.026831,"twenty":-5.342487,"median":-3.782657,"eighty":-3.314983,"marketCap":85379914},{"date":"2023-08-04","current":-2.958445,"twenty":-5.286091,"median":-3.758585,"eighty":-2.99472,"marketCap":83450898},{"date":"2023-08-11","current":-2.973312,"twenty":-5.075638,"median":-3.643386,"eighty":-2.969744,"marketCap":83870250},{"date":"2023-08-18","current":-2.842099,"twenty":-4.570137,"median":-3.57633,"eighty":-2.953093,"marketCap":83656289},{"date":"2023-08-25","current":-2.726636,"twenty":-4.18018,"median":-3.222136,"eighty":-2.868421,"marketCap":79553028},{"date":"2023-09-01","current":-2.370739,"twenty":-4.067388,"median":-3.000071,"eighty":-2.849368,"marketCap":69169264},{"date":"2023-09-07","current":-2.433882,"twenty":-3.951844,"median":-2.973312,"eighty":-2.844375,"marketCap":71011545},{"date":"2023-09-15","current":-2.413791,"twenty":-3.886508,"median":-2.973312,"eighty":-2.761879,"marketCap":70425365},{"date":"2023-09-22","current":-2.293245,"twenty":-3.841116,"median":-2.967365,"eighty":-2.647421,"marketCap":66908283},{"date":"2023-09-29","current":-2.413791,"twenty":-3.792973,"median":-2.953985,"eighty":-2.537207,"marketCap":70425365},{"date":"2023-10-04","current":-2.276024,"twenty":-3.782657,"median":-2.940605,"eighty":-2.474064,"marketCap":66405843},{"date":"2023-10-10","current":-2.098075,"twenty":-3.781281,"median":-2.875192,"eighty":-2.428715,"marketCap":61213961},{"date":"2023-10-19","current":-2.009101,"twenty":-3.779218,"median":-2.868708,"eighty":-2.413791,"marketCap":58618021},{"date":"2023-10-27","current":-1.922996,"twenty":-3.775091,"median":-2.867273,"eighty":-2.413791,"marketCap":56105820},{"date":"2023-11-03","current":-1.871334,"twenty":-3.740703,"median":-2.849368,"eighty":-2.290949,"marketCap":54598499},{"date":"2023-11-10","current":-1.690515,"twenty":-3.669177,"median":-2.844944,"eighty":-2.243878,"marketCap":49322877},{"date":"2023-11-17","current":-1.533738,"twenty":-3.658861,"median":-2.768921,"eighty":-2.084298,"marketCap":50453368},{"date":"2023-11-24","current":-1.527374,"twenty":-3.617595,"median":-2.739552,"eighty":-1.974659,"marketCap":50244018},{"date":"2023-12-01","current":-1.565558,"twenty":-3.614157,"median":-2.617571,"eighty":-1.90147,"marketCap":51500118},{"date":"2023-12-08","current":-1.48919,"twenty":-3.583895,"median":-2.583129,"eighty":-1.87076,"marketCap":48987917},{"date":"2023-12-15","current":-1.540102,"twenty":-3.452534,"median":-2.531467,"eighty":-1.708711,"marketCap":50662718},{"date":"2023-12-22","current":-1.476462,"twenty":-3.314983,"median":-2.474064,"eighty":-1.60527,"marketCap":48569217},{"date":"2023-12-29","current":-2.102685,"twenty":-3.232452,"median":-2.429577,"eighty":-1.641927,"marketCap":69169264},{"date":"2024-01-05","current":-2.03949,"twenty":-3.220072,"median":-2.413791,"eighty":-1.611379,"marketCap":67090423},{"date":"2024-01-12","current":-1.576818,"twenty":-3.100826,"median":-2.392265,"eighty":-1.585578,"marketCap":51870515},{"date":"2024-01-19","current":-1.427896,"twenty":-3.005423,"median":-2.30616,"eighty":-1.564031,"marketCap":46971633},{"date":"2024-01-26","current":-1.124213,"twenty":-2.973312,"median":-2.283466,"eighty":-1.540772,"marketCap":36981756},{"date":"2024-02-02","current":-1.314015,"twenty":-2.973312,"median":-2.260238,"eighty":-1.528392,"marketCap":43225429},{"date":"2024-02-09","current":-1.226414,"twenty":-2.973312,"median":-2.227231,"eighty":-1.508027,"marketCap":40343734},{"date":"2024-02-16","current":-1.220574,"twenty":-2.970933,"median":-2.10038,"eighty":-1.496317,"marketCap":40151621},{"date":"2024-02-23","current":-1.170933,"twenty":-2.967365,"median":-2.077039,"eighty":-1.484607,"marketCap":38518660},{"date":"2024-03-01","current":-1.185534,"twenty":-2.965581,"median":-2.037802,"eighty":-1.427936,"marketCap":38998943},{"date":"2024-03-08","current":-1.305255,"twenty":-2.958445,"median":-1.951697,"eighty":-1.350807,"marketCap":42937259},{"date":"2024-03-15","current":-1.530098,"twenty":-2.956661,"median":-1.917256,"eighty":-1.360152,"marketCap":50333611},{"date":"2024-03-22","current":-1.927222,"twenty":-2.947741,"median":-1.909363,"eighty":-1.380707,"marketCap":63397296},{"date":"2024-03-28","current":-2.178345,"twenty":-2.940605,"median":-1.925109,"eighty":-1.425549,"marketCap":71658156},{"date":"2024-04-05","current":-2.18389,"twenty":-2.875192,"median":-1.928736,"eighty":-1.427896,"marketCap":76862025},{"date":"2024-04-12","current":-2.872164,"twenty":-2.872164,"median":-2.000282,"eighty":-1.428095,"marketCap":101085828},{"date":"2024-04-19","current":-2.390082,"twenty":-2.870144,"median":-2.037802,"eighty":-1.436656,"marketCap":84118945},{"date":"2024-04-26","current":-2.64274,"twenty":-2.867273,"median":-2.070475,"eighty":-1.460017,"marketCap":93011227},{"date":"2024-05-03","current":-2.613699,"twenty":-2.860548,"median":-2.080854,"eighty":-1.476462,"marketCap":91989126},{"date":"2024-05-10","current":-2.758904,"twenty":-2.852923,"median":-2.121507,"eighty":-1.483377,"marketCap":97099633},{"date":"2024-05-17","current":-2.458726,"twenty":-2.860548,"median":-2.154849,"eighty":-1.484098,"marketCap":95873111},{"date":"2024-05-24","current":-2.3198,"twenty":-2.852923,"median":-2.20556,"eighty":-1.486644,"marketCap":90455973},{"date":"2024-05-31","current":-1.968554,"twenty":-2.850079,"median":-2.181118,"eighty":-1.488681,"marketCap":76759815},{"date":"2024-06-07","current":-2.125179,"twenty":-2.849368,"median":-2.152608,"eighty":-1.489212,"marketCap":82867106},{"date":"2024-06-14","current":-2.233016,"twenty":-2.846714,"median":-2.152608,"eighty":-1.492255,"marketCap":87071996},{"date":"2024-06-21","current":-1.741174,"twenty":-2.844944,"median":-2.140329,"eighty":-1.496317,"marketCap":67893594},{"date":"2024-06-28","current":-1.812189,"twenty":-2.844944,"median":-2.140329,"eighty":-1.498354,"marketCap":70662668},{"date":"2024-07-05","current":-0.967903,"twenty":-2.843237,"median":-2.110101,"eighty":-1.488172,"marketCap":37741454},{"date":"2024-07-12","current":-1.249432,"twenty":-2.834001,"median":-2.100781,"eighty":-1.469884,"marketCap":48719089},{"date":"2024-07-15","current":-1.260464,"twenty":-2.831302,"median":-2.098877,"eighty":-1.455345,"marketCap":49149280},{"date":"2024-08-02","current":-1.401267,"twenty":-2.828603,"median":-2.098877,"eighty":-1.436656,"marketCap":54639616},{"date":"2024-08-09","current":-1.290931,"twenty":-2.802466,"median":-2.080854,"eighty":-1.401267,"marketCap":50337284},{"date":"2024-08-16","current":-1.201045,"twenty":-2.796658,"median":-2.072003,"eighty":-1.349055,"marketCap":46438413},{"date":"2024-08-23","current":-1.241178,"twenty":-2.769689,"median":-2.062918,"eighty":-1.296495,"marketCap":47990130},{"date":"2024-08-30","current":-1.113164,"twenty":-2.768153,"median":-2.038646,"eighty":-1.281895,"marketCap":43040476},{"date":"2024-09-06","current":-1.110381,"twenty":-2.760754,"median":-2.011962,"eighty":-1.261256,"marketCap":42932874},{"date":"2024-09-13","current":-1.132616,"twenty":-2.753755,"median":-1.991463,"eighty":-1.24953,"marketCap":43792608},{"date":"2024-09-20","current":-1.430415,"twenty":-2.736707,"median":-1.971607,"eighty":-1.23844,"marketCap":55307011},{"date":"2024-09-27","current":-1.355277,"twenty":-2.727862,"median":-1.927222,"eighty":-1.247781,"marketCap":52401779},{"date":"2024-10-04","current":-1.35806,"twenty":-2.717602,"median":-1.920126,"eighty":-1.24953,"marketCap":52509380},{"date":"2024-10-11","current":-1.333014,"twenty":-2.703726,"median":-1.89225,"eighty":-1.251663,"marketCap":51540970},{"date":"2024-10-18","current":-1.327448,"twenty":-2.69392,"median":-1.871334,"eighty":-1.251663,"marketCap":51325767},{"date":"2024-10-25","current":-1.330231,"twenty":-2.68748,"median":-1.868821,"eighty":-1.256738,"marketCap":51433368},{"date":"2024-10-31","current":-1.15769,"twenty":-2.682816,"median":-1.860061,"eighty":-1.249543,"marketCap":44762095},{"date":"2024-11-08","current":-1.282921,"twenty":-2.678751,"median":-1.809791,"eighty":-1.251136,"marketCap":49604148},{"date":"2024-11-15","current":-1.251898,"twenty":-2.674104,"median":-1.720841,"eighty":-1.252073,"marketCap":58642648},{"date":"2024-11-22","current":-1.176095,"twenty":-2.654356,"median":-1.667384,"eighty":-1.249488,"marketCap":55091809},{"date":"2024-11-29","current":-1.171024,"twenty":-2.64274,"median":-1.629813,"eighty":-1.227353,"marketCap":54854273},{"date":"2024-12-06","current":-1.106606,"twenty":-2.639384,"median":-1.600178,"eighty":-1.22448,"marketCap":51836749},{"date":"2024-12-13","current":-1.148018,"twenty":-2.631897,"median":-1.571188,"eighty":-1.222594,"marketCap":53776586},{"date":"2024-12-20","current":-1.167573,"twenty":-2.62396,"median":-1.563013,"eighty":-1.217317,"marketCap":54692620},{"date":"2024-12-27","current":-1.166423,"twenty":-2.616797,"median":-1.547739,"eighty":-1.213926,"marketCap":54638735},{"date":"2025-01-03","current":-1.182527,"twenty":-2.613699,"median":-1.540102,"eighty":-1.211814,"marketCap":55393116},{"date":"2025-01-10","current":-1.304461,"twenty":-2.611376,"median":-1.530098,"eighty":-1.211814,"marketCap":61104858},{"date":"2025-01-17","current":-1.48161,"twenty":-2.609328,"median":-1.528647,"eighty":-1.213041,"marketCap":69403049},{"date":"2025-01-24","current":-1.656458,"twenty":-2.608318,"median":-1.528647,"eighty":-1.213574,"marketCap":77593471},{"date":"2025-01-31","current":-2.167199,"twenty":-2.60789,"median":-1.530098,"eighty":-1.21433,"marketCap":101518124},{"date":"2025-02-07","current":-2.162598,"twenty":-2.593884,"median":-1.54094,"eighty":-1.214734,"marketCap":101302587},{"date":"2025-02-14","current":-1.769189,"twenty":-2.583696,"median":-1.557921,"eighty":-1.214981,"marketCap":82874137},{"date":"2025-02-21","current":-1.863515,"twenty":-2.577932,"median":-1.565558,"eighty":-1.217317,"marketCap":87292655},{"date":"2025-02-28","current":-1.902626,"twenty":-2.570137,"median":-1.584118,"eighty":-1.220574,"marketCap":89124723},{"date":"2025-03-07","current":-1.833607,"twenty":-2.564329,"median":-1.603098,"eighty":-1.220574,"marketCap":85891661},{"date":"2025-03-14","current":-2.672649,"twenty":-2.570137,"median":-1.649192,"eighty":-1.221023,"marketCap":125194918},{"date":"2025-03-21","current":-2.747078,"twenty":-2.60789,"median":-1.669929,"eighty":-1.222594,"marketCap":128681358},{"date":"2025-03-28","current":-2.594838,"twenty":-2.612537,"median":-1.719708,"eighty":-1.224155,"marketCap":121550002},{"date":"2025-04-04","current":-1.679468,"twenty":-2.612537,"median":-1.718575,"eighty":-1.22448,"marketCap":87161019},{"date":"2025-04-11","current":-1.557114,"twenty":-2.610061,"median":-1.684991,"eighty":-1.225254,"marketCap":80811079},{"date":"2025-04-17","current":-1.492618,"twenty":-2.608747,"median":-1.667384,"eighty":-1.226414,"marketCap":77463875},{"date":"2025-04-25","current":-1.557114,"twenty":-2.60789,"median":-1.641927,"eighty":-1.226584,"marketCap":80811079},{"date":"2025-05-02","current":-1.541757,"twenty":-2.60528,"median":-1.62119,"eighty":-1.227308,"marketCap":80014126},{"date":"2025-05-07","current":-1.575541,"twenty":-2.597448,"median":-1.624681,"eighty":-1.227443,"marketCap":81767423}],"updateTime":1746730707291}}}